Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Angiogenic Markers for Confirming Term Preeclampsia (noPE-37 Trial): An Open-Label, Randomized Controlled Trial

NCT07193680 is registered in ClinicalTrials.gov with Hospital Universitari Vall d'Hebron Research Institute as lead sponsor.

NCT NCT07193680
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07193680 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Angiogenic Markers for Confirming Term Preeclampsia (noPE-37 Trial): An Open-Label, Randomized Controlled Trial
Lead sponsor
Hospital Universitari Vall d'Hebron Research Institute
Phase
Not applicable
Overall status
Recruiting
Start date
December 4, 2025
Completion date
April 30, 2028
Enrollment
750 (estimated)
Sites
23

Conditions

As the registry lists them; a condition with its own page is linked.

preeclampsia